Folke Per-Olof Wallström

Folke Per-Olof Wallström is the founder of Arosia Communication AB. Current jobs include Chairman at Arosgruppen Fastigheter Fjärdingen AB since 2014, Chairman at Camurus Development AB, and Deputy Director at Reabyran AB. Former jobs include Chief Executive Officer at Q-Med AB, President & Chief Executive Officer at Karo Healthcare AB, Chief Executive Officer at Melacure Therapeutics AB, Chief Executive Officer at Karobio Usa, Chairman at AROSGRUPPEN Holding AB, Chairman at Aros Arkitekter AB, Chairman at Nexttobe AB, Chairman at Patients Pending Ltd., Chairman at Aggal Invest AB, Chairman at Mb Erikssons Bygg & Fastighet AB, Chairman at Chemilia AB, Chairman at Masmastaren Fjardingen AB, Director at Swedish Orphan International Holding AB from 2004 to 2010, Director at Envirotainer AB, Independent Director at Hansa Biopharma AB from 2011 to 2018, Director at Q-linea AB from 2018 to 2023, Director at Mediplast AB, Director at NeoDynamics AB, Deputy Director at Addcode Design AB, Deputy Director at Patients Pending AB, Principal at Bristol Myers Squibb Co., Principal at Astra AB, Principal at Pharmacia AB, and Principal at Organon Pharma (UK) Ltd. Education includes graduation from the University of Uppsala.